Background: Patients with cancer experience financial toxicity from the costs of treatment, as
well as material and psychologic stress related to this burden. A synthesized understanding …

Background: With rising cancer care costs, including high-priced cancer drugs, financial
hardship is increasingly documented among cancer survivors in the United States; research …

Background: Out-of-pocket costs pose a substantial economic burden to cancer patients and
their families. The purpose of this study was to evaluate the literature on out-of-pocket costs …

Background Financial toxicity has traditionally been attributed to the rising costs of cancer
care. As ability to work impacts one's financial situation, limited employment and reduced …

Molecular and immune therapies have revolutionized cancer treatment and improved
patient outcomes and survival. However, the pricing of these drugs has become an issue as …

Attention to survivors of adult cancers formally began more than 30 years ago with the
founding of the National Coalition for Cancer Survivorship by representatives from 20 …

Abstract The National Cancer Policy Forum of the National Academies of Sciences,
Engineering and Medicine sponsored a workshop on July 24 and 25, 2017 on Long-Term …

Purpose Financial toxicity after breast cancer may be exacerbated by adverse treatment
effects, like breast cancer-related lymphedema. As the first study of long-term out-of-pocket …

Patients with cancer face an array of financial consequences as a result of their diagnosis
and treatment, collectively referred to as financial toxicity (FT). In the past 10 years, the body …

Objective Our study examines the financial cost of lymphedema following a diagnosis of
breast cancer and addresses a significant knowledge gap regarding the additional impact of …